Integrated Proteins Limited (BOM:519606)

Integrated Proteins Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	3.33	2.5	0.89	0.31	0.37	0.21
Depreciation & Amortization	-	0.1	0.26	0.29	0.29	0.29
Loss (Gain) From Sale of Assets	-0.67	-0.67	-	-	-	-
Other Operating Activities	-3.02	-1.64	-1.59	-1.61	-1.58	-1.42
Change in Accounts Receivable	-1.11	-	-	-	-	0.04
Change in Accounts Payable	80.01	79.9	-0.44	0.04	0.07	0.04
Change in Other Net Operating Assets	-277.9	-315.84	0.28	-0.24	-0.07	-0.07
Operating Cash Flow	-199.38	-235.65	-0.59	-1.2	-0.93	-0.92
Sale of Property, Plant & Equipment	4.26	4.26	0.43	-	-	-
Investment in Securities	1.53	1.53	0.5	-0.01	-	-
Other Investing Activities	2.77	1.53	1.5	1.56	1.56	1.59
Investing Cash Flow	25.34	24.72	1.48	-0.01	0.11	0.24
Short-Term Debt Issued	-	38.96	-	-	-	-
Long-Term Debt Issued	-	-	-	1.12	0.45	0.34
Total Debt Issued	38.71	38.96	-	1.12	0.45	0.34
Long-Term Debt Repaid	-	-0.35	-1.56	-	-	-
Net Debt Issued (Repaid)	0.33	38.61	-1.56	1.12	0.45	0.34
Issuance of Common Stock	172.59	172.59	-	-	-	-
Other Financing Activities	1.9	-0	-	-	-	-
Financing Cash Flow	174.81	211.19	-1.56	1.12	0.45	0.34
Miscellaneous Cash Flow Adjustments	-	-	-	-	0	-
Net Cash Flow	0.78	0.26	-0.68	-0.1	-0.36	-0.34
Cash Income Tax Paid	0.97	0.8	0.24	0.16	0.15	-0.09
Levered Free Cash Flow	-201.95	-238.51	-0.59	-0.63	-0.35	-0.36
Unlevered Free Cash Flow	-201.82	-238.51	-0.59	-0.63	-0.35	-0.36
Change in Working Capital	-199.01	-235.94	-0.16	-0.19	-0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.